Revvity Inc. (RVTY) To Go Ex-Dividend on October 23rd

by · The Markets Daily

Revvity Inc. (NYSE:RVTY – Get Free Report) declared a quarterly dividend on Friday, July 31st. Investors of record on Friday, October 23rd will be given a dividend of $0.07 per share on Friday, November 13th. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, October 23rd.

Revvity has a payout ratio of 5.1% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Revvity to earn $5.92 per share next year, which means the company should continue to be able to cover its $0.28 annual dividend with an expected future payout ratio of 4.7%.

Revvity Stock Up 0.3%

Shares of NYSE:RVTY traded up $0.48 during trading on Wednesday, hitting $156.50. 270,842 shares of the company were exchanged, compared to its average volume of 1,503,452. The stock has a market cap of $17.46 billion, a price-to-earnings ratio of 74.32, a P/E/G ratio of 2.75 and a beta of 1.06. Revvity has a fifty-two week low of $81.22 and a fifty-two week high of $166.25. The firm has a fifty day moving average price of $137.99 and a two-hundred day moving average price of $114.56. The company has a current ratio of 1.80, a quick ratio of 1.50 and a debt-to-equity ratio of 0.36.

Revvity (NYSE:RVTY – Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, beating the consensus estimate of $1.21 by $0.20. Revvity had a return on equity of 8.34% and a net margin of 8.16%. The company had revenue of $729.69 million during the quarter, compared to the consensus estimate of $702.96 million. During the same quarter in the prior year, the firm posted $1.18 EPS. The firm’s revenue for the quarter was down 1.3% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, research analysts anticipate that Revvity will post 5.36 earnings per share for the current fiscal year.

Revvity Company Profile

(Get Free Report)

Revvity, Inc provides technology, products and services for the life sciences and diagnostics markets. The company supports pharmaceutical and biotechnology research, clinical laboratories and other healthcare organizations with tools used in drug discovery, biological research, disease detection and laboratory testing.

Its offerings include laboratory instruments, reagents, consumables, software and workflow solutions. Key areas include genomics, proteomics, cellular analysis, imaging, screening, automation and reproductive health, as well as newborn screening and other diagnostic applications.

Further Reading